Dielectrophoresis

New Study Demonstrates Efficient Exosome Isolation from Biological Fluids Using Proprietary Technology from Biological Dynamics

Retrieved on: 
Wednesday, July 26, 2023

Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, announced a newly published study in the journal Electrophoresis titled, “ Enhancement of Dielectrophoresis-Based Particle Collection from High Conducting Fluids Due to Partial Electrode Insulation.

Key Points: 
  • Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, announced a newly published study in the journal Electrophoresis titled, “ Enhancement of Dielectrophoresis-Based Particle Collection from High Conducting Fluids Due to Partial Electrode Insulation.
  • ” The collaborative research with Oregon Health & Science University (OHSU) sheds light on the phenomenon occurring on Biological Dynamics’ ExoVerita platform that allows for the capture of biomarkers carried by nanoscale particles.
  • Biological Dynamics’ proprietary lab-on-a-chip platform leverages AC Electrokinetics (ACE) technology for the isolation of exosomes from undiluted biofluids, such as whole blood, plasma, and serum.
  • "I look forward to seeing how the advancements we make with the technique improve the capability of diagnostic tools to detect and analyze diseases."

Mursla Granted Patent for Novel Nanoelectronics Detection System for Exosomes

Retrieved on: 
Wednesday, October 20, 2021

Mursla, a liquid biopsy company, is delighted to announce that it has been granted patent GB 2583550B for its novel nanoelectronics-based sensitive detection method for exosomes.

Key Points: 
  • Mursla, a liquid biopsy company, is delighted to announce that it has been granted patent GB 2583550B for its novel nanoelectronics-based sensitive detection method for exosomes.
  • Murslas novel technology is a proprietary nanoelectronics approach for the sensitive detection of disease-related exosomes in fluids.
  • Pierre Arsne, Founder & CEO, Mursla said: This newly granted patent is a very positive step forward for our home-grown patent portfolio of exosome technologies, with more pending.
  • Mursla is a Cambridge-based liquid biopsy company based on a novel tech platform, ExoPheno, which traces diseases in biofluids via exosomes.

Novel Cell Sorting and Separation Markets, 2030

Retrieved on: 
Monday, October 7, 2019

DUBLIN, Oct. 7, 2019 /PRNewswire/ -- The "Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity and Other Technologies, 2019-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 7, 2019 /PRNewswire/ -- The "Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity and Other Technologies, 2019-2030" report has been added to ResearchAndMarkets.com's offering.
  • The Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity, and Other Technologies, 2019-2030' report features an extensive study of the current landscape and future outlook of the growing market for novel cell sorting and separation technologies (beyond conventional methods).
  • However, conventional cell sorting techniques, including adherence-based sorting, membrane filtration-based sorting, and fluorescence- and magnetic-based sorting, are limited by exorbitant operational costs, time-consuming procedures, and the need for complex biochemical labels.
  • An in-depth analysis of the patents that have been filed/granted related to novel cell sorting and separation technologies, since 2014.

Global Novel Cell Sorting and Separation Market Report 2019-2030: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity - ResearchAndMarkets.com

Retrieved on: 
Monday, October 7, 2019

The "Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity and Other Technologies, 2019-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity and Other Technologies, 2019-2030" report has been added to ResearchAndMarkets.com's offering.
  • The Novel Cell Sorting and Separation Market report features an extensive study of the current landscape and future outlook of the growing market for novel cell sorting and separation technologies (beyond conventional methods).
  • The study presents detailed analyses of cell sorters, cell isolation kits, and affiliated consumables and reagents, that are based on the aforementioned technologies.
  • One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the novel cell sorting and separation market.

Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy-activated, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Photoacoustics, Traceless Affinity and Other Technologies, 2019-2030

Retrieved on: 
Tuesday, October 1, 2019

It offers a high-level view on the likely evolution of novel cell sorting and separation market in the mid-long term.

Key Points: 
  • It offers a high-level view on the likely evolution of novel cell sorting and separation market in the mid-long term.
  • The chapter also includes detailed sections on the novel cell sorting and separation technologies (such as acoustophoresis, buoyancy-activated, dielectrophoresis, magnetophoretics, microfluidics, optoelectronics, photoacoustics, traceless affinity, and others), highlighting their advantages and challenges.
  • For this analysis, we considered those patents that have been filed / granted related to novel cell sorting and separation technologies, since 2014.
  • Chapter 11 provides information on funding instances and investments that have been made within the novel cell sorting and separation domain.